Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CHAT | P28329 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.35 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.35 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.35 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1611013 | 0.75 | CHAT (0.43) | CA1CA2CHATALDH1A1TSHR | |
| SCHEMBL6003313 | 0.72 | CA1 (0.40) | CA1CA2CHATALDH1A1TSHR | |
| SCHEMBL3254667 | 0.72 | KIF11 (0.46) | ALDH1A1TSHRHSD17B10TDP1CYP1A2 | |
| SCHEMBL59702 | 0.72 | CA1 (0.69) | CA1CA2CHATALDH1A1TSHR | |
| SCHEMBL5865111 | 0.72 | CA1 (0.47) | CA1CA2CHATALDH1A1TSHR | |
| SCHEMBL2776015 | 0.71 | CHAT (0.60) | CA1CA2CHATALDH1A1TSHR | |
| SCHEMBL29661843 | 0.71 | CHAT (0.60) | CA1CA2CHATALDH1A1TSHR | |
| SCHEMBL814962 | 0.71 | HPRT1 (0.52) | CA1CA2CHATALDH1A1TSHR | |
| SCHEMBL1141298 | 0.71 | HPRT1 (0.52) | CA1CA2CHATALDH1A1TSHR | |
| SCHEMBL10804459 | 0.71 | HPRT1 (0.52) | CA1CA2CHATALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3131655-B1 | METHOD FOR THE QUANTIFICATION OF PARASITE EGGS IN FECES | MEP Equine Solutions LLC (US) | 2020-12-02 | — | — | EP | claimed |
| EP-2404550-B1 | Systems and methods of 4D electromagnetic tomographic (EMT) differential (dynamic) fused imaging | EMIMAGING LTD (GB) | 2015-11-11 | — | — | EP | claimed |
| US-20120010493-A1 | SYSTEMS AND METHODS OF 4D ELECTROMAGNETIC TOMOGRAPHIC (EMT) DIFFERENTIAL (DYNAMIC) FUSED IMAGING | EMTENSOR GMBH (AT) | 2012-01-12 | — | — | US | claimed |
| EP-2404550-A1 | Systems and methods of 4D electromagnetic tomographic (EMT) differential (dynamic) fused imaging | EMImaging Limited (GB) | 2012-01-11 | — | — | EP | claimed |
| US-20080220286-A1 | Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films | TSINGHUA UNIVERSITY (CN) | 2008-09-11 | — | — | US | claimed |
| US-7239731-B1 | System and method for non-destructive functional imaging and mapping of electrical excitation of biological tissues using electromagnetic field tomography and spectroscopy | EMIMAGING LTD (GB) | 2007-07-03 | — | — | US | claimed |
| CN-111201328-B | Detection of recombinant enzyme polymerase amplification using double hapten probes | 雅培诊断产品士嘉堡公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118086454-A | Method for detecting dephosphorylation activity of T4 polynucleotide kinase 3' end, probe set and kit | 深圳市真迈生物科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-111527257-B | Fabric treatment composition and method | HBI品牌服饰企业有限公司 | 2022-01-28 | — | — | CN | disclosed |
| US-20210275806-A1 | CATHETER SYSTEMS | ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC. | 2021-09-09 | — | — | US | disclosed |
| US-11000684-B2 | Catheter systems | ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC. (US) | 2021-05-11 | — | — | US | disclosed |
| CN-112384808-A | Methods for mitigating drug target interference in anti-drug antibody (ADA) immunoassays | 里珍纳龙药品有限公司 | 2021-02-19 | — | — | CN | disclosed |
| US-20200269038-A1 | CATHETER SYSTEMS | ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC. | 2020-08-27 | — | — | US | disclosed |
| US-20110114930-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG MOBILE DISPLAY CO., LTD., (KR) | 2011-05-19 | — | — | US | disclosed |
| US-20090042227-A1 | AMINO(OLIGO)THIOPHENE DYES, PREPARATION THEREOF, AND OPTICAL METHODS OF USE | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2009-02-12 | — | — | US | disclosed |
| US-20080220286-A1 | Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films | TSINGHUA UNIVERSITY (CN) | 2008-09-11 | — | — | US | disclosed |
| US-7239731-B1 | System and method for non-destructive functional imaging and mapping of electrical excitation of biological tissues using electromagnetic field tomography and spectroscopy | EMIMAGING LTD (GB) | 2007-07-03 | — | — | US | disclosed |
| EP-1026222-B1 | Organic material for electroluminescent device and electroluminescent device using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 2002-09-18 | — | — | EP | disclosed |
| US-6391482-B1 | 4,4,8,8-TETRAKIS(1H-PYRAZOL-1-YL)PYRAZABOLE; HIGH SPEED RESPONSE | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2002-05-21 | — | — | US | disclosed |
| EP-1026222-A2 | Organic material for electroluminescent device and electroluminescent device using the same | Matsushita Electric Industrial Co., Ltd. (JP) | 2000-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080220286-A1 | Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films | EED, DDT, RABL6 | CA1 4545/4885CA2 4392/4885CHAT 151/4885 |
| US-20090042227-A1 | AMINO(OLIGO)THIOPHENE DYES, PREPARATION THEREOF, AND OPTICAL METHODS OF USE | NLN, NME4, OAT | CA1 2462/4885CA2 1203/4885CHAT 633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.